MBL.IS: Great Atmosphere at a Conference on Thought-Provoking Topics
Originally appearing here (Archived)
MAPS in the Media
Forbes: New Study Supports MDMA As A Treatment For PTSD
Summary: Forbes publishes an overview of the announcement surrounding a successful confirmatory Phase 3 trial of MDMA-assisted therapy for posttraumatic stress disorder (PTSD). “The Phase 3 confirmatory …
The Intercept: Party Drugs for PTSD: Study Moves Therapeutic Use of MDMA Toward Approval
Summary: The Intercept covers the recently announced positive results from the clinical trial testing MDMA as a treatment for post-traumatic stress disorder. “MDMA earned positive results for treating …
Medscape: More Support for MDMA-Assisted Psychotherapy for PTSD
Summary: Medscape highlights MAPS’ recent announcement of a successful confirmatory Phase 3 trial of MDMA-assisted therapy for posttraumatic stress disorder (PTSD). “A new study provides strong …
Boulder Weekly: Training Psychedelic Therapists
Originally appearing here (Archived)
The Psychedelic Podcast by Third Wave: Healing the Heart of Humanity: Legalizing Psychedelic Medicine
Originally appearing here (Archived)
CBS Austin: SXSW 2023 Keynote Session and Third Round of Featured Speakers Announced
Originally appearing here (Archived)
High Times: House Lawmakers Launch Bipartisan Psychedelics Caucus
Summary: Two House lawmakers have joined to form a bipartisan caucus to advocate for research into the therapeutic potential of psychedelic drugs. Originally appearing here (Archived)
Psychedelic Spotlight: The Psychedelics Industry in 2022 Was a Wild Ride
Originally appearing here (Archived)
The Dales Report: Potential For MDMA-Assisted Therapy Approval Boosts Psychedelic Stocks Early In 2023
Originally appearing here (Archived)
Green Market Report: Congress Hops on Psychedelics Juggernaut with a New Caucus
Originally appearing here (Archived)
BBC Sounds: MDMA for PTSD
Originally appearing here (Archived)
